The latest Outpatient Medicine CME updates for nurse practitioners, physician assistants and other healthcare professionals. Taught LIVE by practicing physicians. Relevant, up-to-date studies. Live Stream available. Save $100 w/discount code: ENP100

The latest Hospital Medicine CME updates for nurse practitioners, physician assistants and other healthcare professionals. Taught LIVE by practicing physicians. Relevant, up-to-date studies. Live Stream available. Save $100 with discount code: ENP100

Elevate-Derm Fall Conference promises an enriching blend of education, innovation, and networking. It offers a comprehensive platform for attendees to stay at the forefront of dermatologic practice and engage in thought-provoking sessions.

Join us for this live national webinar designed to bridge real-world patient perspectives with the latest advances in metastatic breast cancer (MBC) care.

The PREPARE Summit program, led by experts, this program emphasizes the use of validated screening tools, clinical signs and symptoms, and emerging biomarkers to differentiate normal aging from early cognitive.

Embark on the path to become an expert injector!  This program provides you with the knowledge and practical skills needed to succeed.  Class size is limited to 8, ensuring you receive an individualized training environment.  Models are provided.

Join us for a live webinar where expert faculty will provide actionable insights on improving patient identification and engagement for CAR T-cell therapy in diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL).

Join us for a live, interactive TheraTalk session with an expert panel of nationally recognized lipid specialists as they review the latest guideline recommendations, pivotal evidence, and evolving strategies for LDL-C management.

Platinum-resistant ovarian cancer (PROC) remains one of the most significant challenges in gynecologic oncology; however, novel antibody-drug conjugates (ADCs) and innovative investigational therapies are opening new avenues to improve outcomes.

Novel targeted therapies offer new hope to slow progression and improve quality of life in meaningful ways for patients with primary biliary cholangitis (PBC).